Skip to main content
Top
Published in: BMC Medicine 1/2013

Open Access 01-12-2013 | Research article

High-end normal adrenocorticotropic hormone and cortisol levels are associated with specific cardiovascular risk factors in pediatric obesity: a cross-sectional study

Authors: Flavia Prodam, Roberta Ricotti, Valentina Agarla, Silvia Parlamento, Giulia Genoni, Caterina Balossini, Gillian Elisabeth Walker, Gianluca Aimaretti, Gianni Bona, Simonetta Bellone

Published in: BMC Medicine | Issue 1/2013

Login to get access

Abstract

Background

The hypothalamic-pituitary-adrenal (HPA) axis, and in particular cortisol, has been reported to be involved in obesity-associated metabolic disturbances in adults and in selected populations of adolescents. The aim of this study was to investigate the association between morning adrenocorticotropic hormone (ACTH) and cortisol levels and cardiovascular risk factors in overweight or obese Caucasian children and adolescents.

Methods

This cross-sectional study of 450 obese children and adolescents (aged 4 to 18 years) was performed in a tertiary referral center. ACTH, cortisol, cardiovascular risk factors (fasting and post-challenge glucose, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, triglycerides, and hypertension) and insulin resistance were evaluated. All analyses were corrected for confounding factors (sex, age, puberty, body mass index), and odds ratios were determined.

Results

ACTH and cortisol levels were positively associated with systolic and diastolic blood pressure, triglycerides, fasting glucose and insulin resistance. Cortisol, but not ACTH, was also positively associated with LDL-cholesterol. When adjusted for confounding factors, an association between ACTH and 2 h post-oral glucose tolerance test glucose was revealed. After stratification according to cardiovascular risk factors and adjustment for possible confounding factors, ACTH levels were significantly higher in subjects with triglycerides ≥90th percentile (P <0.02) and impaired fasting glucose or glucose tolerance (P <0.001). Higher cortisol levels were found in subjects with blood pressure ≥95th percentile and LDL-cholesterol ≥90th percentile. Overall, the highest tertiles of ACTH (>5.92 pmol/l) and cortisol (>383.5 nmol/l) although within the normal range were associated with increases in cardiovascular risk factors in this population.

Conclusions

In obese children and adolescents, high morning ACTH and cortisol levels are associated with cardiovascular risk factors. High ACTH levels are associated with high triglyceride levels and hyperglycemia, while high cortisol is associated with hypertension and high LDL-cholesterol. These specific relationships suggest complex mechanisms through which the HPA axis may contribute to metabolic impairments in obesity, and merit further investigations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ogden CL, Carroll MD, Kit BK, Flegal KM: Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief. 2012, 82: 1-8.PubMed Ogden CL, Carroll MD, Kit BK, Flegal KM: Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief. 2012, 82: 1-8.PubMed
2.
go back to reference De Onis M, Blossner M, Borghi E: Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010, 92: 1257-10.3945/ajcn.2010.29786.CrossRefPubMed De Onis M, Blossner M, Borghi E: Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr. 2010, 92: 1257-10.3945/ajcn.2010.29786.CrossRefPubMed
3.
go back to reference Nadeau KJ, Maahs DM, Daniels SR, Eckel RH: Childhood obesity and cardiovascular disease: links and prevention strategies. Nat Rev Cardiol. 2011, 8: 513-525. 10.1038/nrcardio.2011.86.CrossRefPubMedPubMedCentral Nadeau KJ, Maahs DM, Daniels SR, Eckel RH: Childhood obesity and cardiovascular disease: links and prevention strategies. Nat Rev Cardiol. 2011, 8: 513-525. 10.1038/nrcardio.2011.86.CrossRefPubMedPubMedCentral
4.
go back to reference Whitworth JA, Brown MA, Kelly JJ, Williamson PM: Mechanism of cortisol-induced hypertension in humans. Steroids. 1995, 60: 76-80. 10.1016/0039-128X(94)00033-9.CrossRefPubMed Whitworth JA, Brown MA, Kelly JJ, Williamson PM: Mechanism of cortisol-induced hypertension in humans. Steroids. 1995, 60: 76-80. 10.1016/0039-128X(94)00033-9.CrossRefPubMed
5.
go back to reference Pasquali R, Vicennati V, Gambineri A, Pagotto U: Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity. Int J Obes (Lond). 2008, 32: 1764-1779. 10.1038/ijo.2008.129.CrossRef Pasquali R, Vicennati V, Gambineri A, Pagotto U: Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity. Int J Obes (Lond). 2008, 32: 1764-1779. 10.1038/ijo.2008.129.CrossRef
6.
go back to reference Sukhija R, Kakar P, Mehta V, Mehta JL: Enhanced 11β-hydroxysteroid dehydrogenase activity, the metabolic syndrome, and systemic hypertension. Am J Cardiol. 2006, 98: 544-548. 10.1016/j.amjcard.2006.03.028.CrossRefPubMed Sukhija R, Kakar P, Mehta V, Mehta JL: Enhanced 11β-hydroxysteroid dehydrogenase activity, the metabolic syndrome, and systemic hypertension. Am J Cardiol. 2006, 98: 544-548. 10.1016/j.amjcard.2006.03.028.CrossRefPubMed
7.
go back to reference Walker BR: Glucocorticoids and cardiovascular disease. Eur J Endocrinol. 2007, 157: 545-559. 10.1530/EJE-07-0455.CrossRefPubMed Walker BR: Glucocorticoids and cardiovascular disease. Eur J Endocrinol. 2007, 157: 545-559. 10.1530/EJE-07-0455.CrossRefPubMed
8.
go back to reference Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP: Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009, 94: 2692-2701. 10.1210/jc.2009-0370.CrossRefPubMed Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP: Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab. 2009, 94: 2692-2701. 10.1210/jc.2009-0370.CrossRefPubMed
9.
go back to reference Reinehr T, Andler W: Cortisol and its relation to insulin resistance before and after weight loss in obese children. Horm Res. 2004, 62: 107-112. 10.1159/000079841.CrossRefPubMed Reinehr T, Andler W: Cortisol and its relation to insulin resistance before and after weight loss in obese children. Horm Res. 2004, 62: 107-112. 10.1159/000079841.CrossRefPubMed
10.
go back to reference DeSantis AS, Adam EK, Doane LD, Mineka S, Zinbarg RE, Craske MG: Racial/ethnic differences in cortisol diurnal rhythms in a community sample of adolescents. J Adolesc Health. 2007, 41: 3-13. 10.1016/j.jadohealth.2007.03.006.CrossRefPubMed DeSantis AS, Adam EK, Doane LD, Mineka S, Zinbarg RE, Craske MG: Racial/ethnic differences in cortisol diurnal rhythms in a community sample of adolescents. J Adolesc Health. 2007, 41: 3-13. 10.1016/j.jadohealth.2007.03.006.CrossRefPubMed
11.
go back to reference Adam TC, Hasson RE, Ventura EE, Toledo-Corral C, Le KA, Mahurkar S, Lane CJ, Weigensberg MJ, Goran MI: Cortisol is negatively associated with insulin sensitivity in overweight Latino youth. J Clin Endocrinol Metab. 2010, 95: 4729-4735. 10.1210/jc.2010-0322.CrossRefPubMedPubMedCentral Adam TC, Hasson RE, Ventura EE, Toledo-Corral C, Le KA, Mahurkar S, Lane CJ, Weigensberg MJ, Goran MI: Cortisol is negatively associated with insulin sensitivity in overweight Latino youth. J Clin Endocrinol Metab. 2010, 95: 4729-4735. 10.1210/jc.2010-0322.CrossRefPubMedPubMedCentral
12.
go back to reference Weigensberg MJ, Toledo-Corral CM, Goran MI: Association between the metabolic syndrome and serum cortisol in overweight Latino youth. J Clin Endocrinol Metab. 2008, 93: 1372-1378. 10.1210/jc.2007-2309.CrossRefPubMedPubMedCentral Weigensberg MJ, Toledo-Corral CM, Goran MI: Association between the metabolic syndrome and serum cortisol in overweight Latino youth. J Clin Endocrinol Metab. 2008, 93: 1372-1378. 10.1210/jc.2007-2309.CrossRefPubMedPubMedCentral
13.
go back to reference Barat P, Gayard-Cros M, Andrew R, Corcuff JB, Jouret B, Barthe N, Perez P, Germain C, Tauber M, Walker BR, Mormede P, Duclos M: Truncal distribution of fat mass, metabolic profile and hypothalamic-pituitary adrenal axis activity in prepubertal obese children. J Pediatr. 2007, 150: 535-539. 10.1016/j.jpeds.2007.01.029.CrossRefPubMed Barat P, Gayard-Cros M, Andrew R, Corcuff JB, Jouret B, Barthe N, Perez P, Germain C, Tauber M, Walker BR, Mormede P, Duclos M: Truncal distribution of fat mass, metabolic profile and hypothalamic-pituitary adrenal axis activity in prepubertal obese children. J Pediatr. 2007, 150: 535-539. 10.1016/j.jpeds.2007.01.029.CrossRefPubMed
14.
go back to reference Iwen KA, Senyaman O, Schwartz A, Drenckhan M, Meier B, Hadaschik D, Klein J: Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes. J Endocrinol. 2008, 196: 465-472. 10.1677/JOE-07-0299.CrossRefPubMed Iwen KA, Senyaman O, Schwartz A, Drenckhan M, Meier B, Hadaschik D, Klein J: Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes. J Endocrinol. 2008, 196: 465-472. 10.1677/JOE-07-0299.CrossRefPubMed
15.
go back to reference Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A: Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest. 2006, 29: 581-593.CrossRefPubMed Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A: Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest. 2006, 29: 581-593.CrossRefPubMed
16.
go back to reference Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM: The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008, 93: 1526-1540. 10.1210/jc.2008-0125.CrossRefPubMedPubMedCentral Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM: The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008, 93: 1526-1540. 10.1210/jc.2008-0125.CrossRefPubMedPubMedCentral
17.
go back to reference Prodam F, Trovato L, Demarchi I, Busti A, Petri A, Moia S, Walker GE, Aimaretti G, Bona G, Bellone S: Unacylated, acylated ghrelin and obestatin levels are differently inhibited by oral glucose load in pediatric obesity: Association with insulin sensitivity and metabolic alterations. eSpen. 2011, 6: e109-e115. Prodam F, Trovato L, Demarchi I, Busti A, Petri A, Moia S, Walker GE, Aimaretti G, Bona G, Bellone S: Unacylated, acylated ghrelin and obestatin levels are differently inhibited by oral glucose load in pediatric obesity: Association with insulin sensitivity and metabolic alterations. eSpen. 2011, 6: e109-e115.
18.
go back to reference Cruz ML, Goran MI: The metabolic syndrome in children and adolescents. Curr Diab Rep. 2004, 4: 53-62. 10.1007/s11892-004-0012-x.CrossRefPubMed Cruz ML, Goran MI: The metabolic syndrome in children and adolescents. Curr Diab Rep. 2004, 4: 53-62. 10.1007/s11892-004-0012-x.CrossRefPubMed
19.
go back to reference National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004, 114: 555-576.CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004, 114: 555-576.CrossRef
20.
go back to reference Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003, 157: 821-827. 10.1001/archpedi.157.8.821.CrossRefPubMed Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003, 157: 821-827. 10.1001/archpedi.157.8.821.CrossRefPubMed
21.
go back to reference de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N: Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004, 110: 2494-2497. 10.1161/01.CIR.0000145117.40114.C7.CrossRefPubMed de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N: Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004, 110: 2494-2497. 10.1161/01.CIR.0000145117.40114.C7.CrossRefPubMed
22.
go back to reference Daniels SR, Greer FR: Lipid screening and cardiovascular health in childhood. Pediatrics. 2008, 122: 198-208. 10.1542/peds.2008-1349.CrossRefPubMed Daniels SR, Greer FR: Lipid screening and cardiovascular health in childhood. Pediatrics. 2008, 122: 198-208. 10.1542/peds.2008-1349.CrossRefPubMed
23.
go back to reference Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004, 350: 2362-2374. 10.1056/NEJMoa031049.CrossRefPubMed Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S: Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004, 350: 2362-2374. 10.1056/NEJMoa031049.CrossRefPubMed
24.
go back to reference Duncan GE, Li SM, Zhou XH: Prevalence and trends of a metabolic syndrome phenotype among U.S. Adolescents, 1999-2000. Diabetes Care. 2004, 27: 2438-2443. 10.2337/diacare.27.10.2438.CrossRefPubMed Duncan GE, Li SM, Zhou XH: Prevalence and trends of a metabolic syndrome phenotype among U.S. Adolescents, 1999-2000. Diabetes Care. 2004, 27: 2438-2443. 10.2337/diacare.27.10.2438.CrossRefPubMed
25.
26.
go back to reference Pasquali R, Vicennati V: Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes. Int J Obes Relat Metab Disord. 2000, 24: S47-49.CrossRefPubMed Pasquali R, Vicennati V: Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes. Int J Obes Relat Metab Disord. 2000, 24: S47-49.CrossRefPubMed
27.
go back to reference Rosmond R, Dallman MF, Björntorp P: Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab. 1998, 83: 1853-1859. 10.1210/jc.83.6.1853.PubMed Rosmond R, Dallman MF, Björntorp P: Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab. 1998, 83: 1853-1859. 10.1210/jc.83.6.1853.PubMed
28.
go back to reference Knutsson U, Dahlgren J, Marcus C, Rosberg S, Brönnegård M, Stierna P, Albertsson-Wikland K: Circadian cortisol rhythms in healthy boys and girls: relationship with age, growth, body composition, and pubertal development. J Clin Endocrinol Metab. 1998, 82: 536-540. Knutsson U, Dahlgren J, Marcus C, Rosberg S, Brönnegård M, Stierna P, Albertsson-Wikland K: Circadian cortisol rhythms in healthy boys and girls: relationship with age, growth, body composition, and pubertal development. J Clin Endocrinol Metab. 1998, 82: 536-540.
29.
go back to reference Dimitriou T, Maser-Gluth C, Remer T: Adrenocortical activity in healthy children is associated with fat mass. Am J Clin Nutr. 2003, 77: 731-736.PubMed Dimitriou T, Maser-Gluth C, Remer T: Adrenocortical activity in healthy children is associated with fat mass. Am J Clin Nutr. 2003, 77: 731-736.PubMed
30.
go back to reference Jessop DS, Dallman MF, Fleming D, Lightman SL: Resistance to glucocorticoid feedback in obesity. J Clin Endocrinol Metab. 2003, 86: 4109-4114.CrossRef Jessop DS, Dallman MF, Fleming D, Lightman SL: Resistance to glucocorticoid feedback in obesity. J Clin Endocrinol Metab. 2003, 86: 4109-4114.CrossRef
31.
go back to reference Chalew SA, Lozano RA, Armour KM, Zadik Z, Kowarski AA: Reduction of plasma cortisol levels in childhood obesity. J Pediatr. 1991, 119: 778-780. 10.1016/S0022-3476(05)80302-6.CrossRefPubMed Chalew SA, Lozano RA, Armour KM, Zadik Z, Kowarski AA: Reduction of plasma cortisol levels in childhood obesity. J Pediatr. 1991, 119: 778-780. 10.1016/S0022-3476(05)80302-6.CrossRefPubMed
32.
go back to reference Soros A, Zadik Z, Chalew S: Adaptive and maladaptive cortisol responses to pediatric obesity. Med Hypotheses. 2008, 71: 394-398. 10.1016/j.mehy.2008.04.020.CrossRefPubMed Soros A, Zadik Z, Chalew S: Adaptive and maladaptive cortisol responses to pediatric obesity. Med Hypotheses. 2008, 71: 394-398. 10.1016/j.mehy.2008.04.020.CrossRefPubMed
33.
go back to reference Wudy SA, Hartmann MF, Remer T: Sexual dimorphism in cortisol secretion starts after age 10 in healthy children: urinary cortisol metabolite excretion rates during growth. Am J Physiol Endocrinol Metab. 2007, 293: E970-E976. 10.1152/ajpendo.00495.2006.CrossRefPubMed Wudy SA, Hartmann MF, Remer T: Sexual dimorphism in cortisol secretion starts after age 10 in healthy children: urinary cortisol metabolite excretion rates during growth. Am J Physiol Endocrinol Metab. 2007, 293: E970-E976. 10.1152/ajpendo.00495.2006.CrossRefPubMed
34.
go back to reference Gagliardi L, Ho JT, Torpy DJ: Corticosteroid-binding globulin: the clinical significance of altered levels and heritable mutations. Mol Cell Endocrinol. 2010, 316: 24-34. 10.1016/j.mce.2009.07.015.CrossRefPubMed Gagliardi L, Ho JT, Torpy DJ: Corticosteroid-binding globulin: the clinical significance of altered levels and heritable mutations. Mol Cell Endocrinol. 2010, 316: 24-34. 10.1016/j.mce.2009.07.015.CrossRefPubMed
35.
go back to reference Fernandez-Real JM, Pugeat M, Grasa M, Broch M, Vendrell J, Brun J, Ricart W: Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study. J Clin Endocrinol Metab. 2002, 87: 4686-4690. 10.1210/jc.2001-011843.CrossRefPubMed Fernandez-Real JM, Pugeat M, Grasa M, Broch M, Vendrell J, Brun J, Ricart W: Serum corticosteroid-binding globulin concentration and insulin resistance syndrome: a population study. J Clin Endocrinol Metab. 2002, 87: 4686-4690. 10.1210/jc.2001-011843.CrossRefPubMed
36.
go back to reference Witchel SF, DeFranco DB: Mechanisms of disease: regulation of glucocorticoid and receptor levels--impact on the metabolic syndrome. Nat Clin Pract Endocrinol Metab. 2006, 2: 621-631. 10.1038/ncpendmet0323.CrossRefPubMed Witchel SF, DeFranco DB: Mechanisms of disease: regulation of glucocorticoid and receptor levels--impact on the metabolic syndrome. Nat Clin Pract Endocrinol Metab. 2006, 2: 621-631. 10.1038/ncpendmet0323.CrossRefPubMed
37.
go back to reference Arnaldi G, Scandali VM, Trementino L, Cardinaletti M, Appolloni G, Boscaro M: Pathophysiology of dyslipidemia in Cushing's syndrome. Neuroendocrinology. 2010, 92: 86-90. 10.1159/000314213.CrossRefPubMed Arnaldi G, Scandali VM, Trementino L, Cardinaletti M, Appolloni G, Boscaro M: Pathophysiology of dyslipidemia in Cushing's syndrome. Neuroendocrinology. 2010, 92: 86-90. 10.1159/000314213.CrossRefPubMed
38.
go back to reference Berg AL, Rafnsson AT, Johannsson M, Dallongeville J, Arnadottir M: The effects of adrenocorticotrophic hormone and an equivalent dose of cortisol on the serum concentrations of lipids, lipoproteins, and apolipoproteins. Metabolism. 2006, 55: 1083-1087. 10.1016/j.metabol.2006.04.001.CrossRefPubMed Berg AL, Rafnsson AT, Johannsson M, Dallongeville J, Arnadottir M: The effects of adrenocorticotrophic hormone and an equivalent dose of cortisol on the serum concentrations of lipids, lipoproteins, and apolipoproteins. Metabolism. 2006, 55: 1083-1087. 10.1016/j.metabol.2006.04.001.CrossRefPubMed
39.
go back to reference Lambillotte C, Gilon P, Henquin JC: Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest. 1997, 99: 414-423. 10.1172/JCI119175.CrossRefPubMedPubMedCentral Lambillotte C, Gilon P, Henquin JC: Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J Clin Invest. 1997, 99: 414-423. 10.1172/JCI119175.CrossRefPubMedPubMedCentral
40.
go back to reference Pervanidou P, Chrousos GP: Metabolic consequences of stress during childhood and adolescence. Metabolism. 2012, 61: 611-619. 10.1016/j.metabol.2011.10.005.CrossRefPubMed Pervanidou P, Chrousos GP: Metabolic consequences of stress during childhood and adolescence. Metabolism. 2012, 61: 611-619. 10.1016/j.metabol.2011.10.005.CrossRefPubMed
41.
go back to reference Freedman DS, Wang J, Thornton JC, Mei Z, Sopher AB, Pierson RN, Dietz WH, Horlick M: Classification of body fatness by body mass index-for-age categories among children. Arch Pediatr Adolesc Med. 2009, 163: 805-811. 10.1001/archpediatrics.2009.104.CrossRefPubMedPubMedCentral Freedman DS, Wang J, Thornton JC, Mei Z, Sopher AB, Pierson RN, Dietz WH, Horlick M: Classification of body fatness by body mass index-for-age categories among children. Arch Pediatr Adolesc Med. 2009, 163: 805-811. 10.1001/archpediatrics.2009.104.CrossRefPubMedPubMedCentral
Metadata
Title
High-end normal adrenocorticotropic hormone and cortisol levels are associated with specific cardiovascular risk factors in pediatric obesity: a cross-sectional study
Authors
Flavia Prodam
Roberta Ricotti
Valentina Agarla
Silvia Parlamento
Giulia Genoni
Caterina Balossini
Gillian Elisabeth Walker
Gianluca Aimaretti
Gianni Bona
Simonetta Bellone
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2013
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-11-44

Other articles of this Issue 1/2013

BMC Medicine 1/2013 Go to the issue